Paragraphs

India has been famous for arguing that it (and the rest of the developing world) should incur no expense in controlling emissions that cause climate change. The west caused the problem and it should clean it up. That argument is increasingly untenable — both in the fundamental arithmetic of climate change, which is a problem that is impossible to solve without developing country participation, and in the political reality that important western partners will increasingly demand more of India and other developing countries. India’s own public is also demanding more.

The Indian government has outlined a broad plan for what could be done, but the plan still lacks a strategy to inform which efforts offer the most leverage on warming emissions and which are most credible because they align with India’s own interests.

This paper offers a framework for that strategy. It suggests that a large number of options to control warming gases are in India’s own self-interest, and with three case studies it suggests that leverage on emissions could amount to several hundred million tonnes of CO2 annually over the next decade and an even larger quantity by 2030. (For comparison, the Kyoto Protocol has caused worldwide emission reductions of, at most, a couple hundred million tonnes of CO2 per year.) We suggest in addition to identifying self-interest — which is the key concept in the burgeoning literature on “co-benefits” of climate change policy — that it is also important to examine where India and outsiders (e.g., technology providers and donors) have leverage.

One reason that strategies offered to date have remained abstract and difficult to implement is that they are not rooted in a clear understanding of where the Government of India is able to deliver on its promises (and where Indian firms have access to the needed technology and practices). Many ideas are interesting in theory but do not align with the administrative and technological capabilities of the Indian context. As the rest of the world contemplates how to engage with India on the task of controlling emissions it must craft deals that reflect India’s interests, capabilities and leverage on emissions. These deals will not be simple to craft, but there are many precedents for such arrangements in other areas of international cooperation, such as in accession agreements to the WTO.

All Publications button
1
Publication Type
Journal Articles
Publication Date
Journal Publisher
Economic and Political Weekly
Authors
Varun Rai
David G. Victor
-

Pharmaceutical policies are interlinked globally, yet deeply rooted in local culture. The newly published book Prescribing Cultures and Pharmaceutical Policy in the Asia-Pacific, edited by Karen Eggleston, examines how pharmaceuticals and their regulation play an important and often contentious role in the health systems of the Asia-Pacific.

In this colloquium, contributors to Prescribing Cultures discuss how the book analyzes pharmaceutical policy in China, Korea, Japan, Thailand, Taiwan, Australia, and India, focusing on two cross-cutting themes: differences in “prescribing cultures” and physician dispensing; and the challenge of balancing access to drugs with incentives for innovation.

As Michael Reich of Harvard University says in his Forward to Prescribing Cultures,

“The pharmaceutical sector…promises great benefits and also poses enormous risks.… Conflicts abound over public policies, industry strategies, payment mechanisms, professional associations, and dispensing practices—to name just a few of the regional controversies covered in this excellent book.

The tension between emphasizing innovation versus access -- a topic of hot debate on today’s global health policy agenda -- is examined in several chapters…

This book makes a special contribution to our understanding of the pharmaceutical sector in China… Globalization is galloping forward, with Chinese producers pushing the pace at breakneck speed. More and more, our safety depends on China’s ability to get its regulatory act together…”

The colloquium features presentations by Naoko Tomita (Keio University), Anita Wagner (Harvard University), and Karen Eggleston (Stanford FSI Shorenstein Asia-Pacific Research Center). They will give specific examples of how pharmaceutical policy serves as a window into the economic tradeoffs, political compromises, and historical trajectories that shape health systems, as well as how cultural legacies shape and are shaped by the forces of globalization.

Oksenberg Conference Room

Anita Wagner Speaker Harvard University
Naoko Tomita Speaker Keio University

Shorenstein APARC
Stanford University
Encina Hall E301
Stanford, CA 94305-6055

(650) 723-9072 (650) 723-6530
0
Senior Fellow at the Freeman Spogli Institute for International Studies
Center Fellow at the Center for Health Policy and the Center for Primary Care and Outcomes Research
Faculty Research Fellow of the National Bureau of Economic Research
Faculty Affiliate at the Stanford Center on China's Economy and Institutions
karen-0320_cropprd.jpg PhD

Karen Eggleston is a Senior Fellow at the Freeman Spogli Institute for International Studies (FSI) at Stanford University and Director of the Stanford Asia Health Policy Program at the Shorenstein Asia-Pacific Research Center at FSI. She is also a Fellow with the Center for Innovation in Global Health at Stanford University School of Medicine, and a Faculty Research Fellow of the National Bureau of Economic Research (NBER). Her research focuses on government and market roles in the health sector and Asia health policy, especially in China, India, Japan, and Korea; healthcare productivity; and the economics of the demographic transition.

Eggleston earned her PhD in public policy from Harvard University and has MA degrees in economics and Asian studies from the University of Hawaii and a BA in Asian studies summa cum laude (valedictorian) from Dartmouth College. Eggleston studied in China for two years and was a Fulbright scholar in Korea. She served on the Strategic Technical Advisory Committee for the Asia Pacific Observatory on Health Systems and Policies and has been a consultant to the World Bank, the Asian Development Bank, and the WHO regarding health system reforms in the PRC.

Director of the Asia Health Policy Program, Shorenstein Asia-Pacific Research Center
Stanford Health Policy Associate
Faculty Fellow at the Stanford Center at Peking University, June and August of 2016
CV
Date Label
Karen Eggleston Speaker Stanford University
Seminars

Herbert Hoover Memorial Building room 234
434 Galvez Mall, Stanford, CA 94035

650.724.5484
0
dscf2058_-_sumit_ganguly.jpg PhD

Šumit Ganguly is a Senior Fellow and directs the Huntington Program on Strengthening US-India Relations at the Hoover Institution, Stanford University. He is Distinguished Professor of Political Science Emeritus and the Rabindranath Tagore Chair in Indian Cultures and Civilizations Emeritus at Indiana University, Bloomington. He has previously taught at James Madison College of Michigan State University, Hunter College and the Graduate Center of the City University of New York and the University of Texas at Austin.

Professor Ganguly has been a Fellow at the Woodrow Wilson International Center for Scholars in Washington, DC, a Visiting Fellow at the Center for International Security and Cooperation and at the Center on Democracy, Development and the Rule of Law at Stanford University, a Guest Scholar at the Center for Cooperative Monitoring in Albuquerque and a Visiting Scholar at the German Institute for International and Area Studies in Hamburg. He was also the holder of the Ngee Ann Chair in International Politics at the Rajaratnam School for International Studies at Nanyang Technological University in Singapore in the spring term of 2010. In 2018 and 2019 he was an Alexander von Humboldt Fellow at the University of Heidelberg, Germany.

Professor Ganguly is member of the Council on Foreign Relations (New York) and a Fellow of the American Academy of Arts and Sciences. He serves on the editorial boards of Asian Security, Current History, Journal of Democracy, Foreign Policy Analysis, The Nonproliferation Review, Pacific Affairs, International Security and Small Wars and Insurgencies. A specialist on the contemporary politics of South Asia is the author, co-author, editor or co-editor of 20 books on the region. His most recent book (edited with Eswaran Sridharan) is the Oxford Handbook of Indian Politics.

Senior Fellow, Hoover Institution
CDDRL Affiliated Faculty
CDDRL Visiting Scholar, 2009
Affiliate at CISAC
Date Label

As democracy has spread over the past three decades to a majority of the world's states, analytic attention has turned increasingly from explaining regime transitions to evaluating and explaining the character of democratic regimes. Much of the democracy literature of the 1990s was concerned with the consolidation of democratic regimes. In recent years, social scientists as well as democracy practitioners and aid agencies have sought to develop means of framing and assessing the quality of democracy.

-

Ambassador Sheinwald discusses how he envisages international relations will form in the near and far future. He places particular emphasis on the growing importance of the US-China relationship. At the same time, Ambassador Sheinwald explores the EU as a key global power and its necessary cooperation with the US.

Synopsis

Ambassador Sheinwald clearly feels that the international stage is moving. In fact, for him, the change in the international order is accelerating due to the global financial crisis. In this sense, Ambassador Sheinwald explains that the UK has long supported expanding decision-making international institutions such as the UN Security Council. However, the UK still sees the value in intimate, power-focused bodies such as the G8. Ambassador Sheinwald discusses the fact that there is increasingly a sense that a ‘G2’ is developing between the US and China. To Ambassador Sheinwald, this model would not literally work as he argues China needs, at this stage in its development, a multilateral setting to grow into the active and cooperative power we would all like to see it become. At the same time, Ambassador Sheinwald believes that the partnership between the US and China is important in paving a solution to the current economic state and shaping the future global economy. In fact, the UK and the EU welcome this new cooperation between the two powers. Ambassador Sheinwald feels the US and the EU can harness China’s shared global interest on issues such as climate change, in which the EU has played a front role, to develop at stable global relationship. Moreover, he believes that if the US and EU can cooperate to form low carbon economies, it could incentivize China and India to act similarly. However, Ambassador Sheinwald stresses that for non-economic issues the US and China’s relationship is still important but slow moving, and he expresses the belief that it will take decades for any real ‘G2’ to emerge.

In the meantime, Ambassador Sheinwald argues that while the US looks round the world for support on key issues, it will find that the EU shares the most values and has the capacity to promote them. He cites the enormous investments between the two in comparison to the US and China to show the scale of the US and the EU’s relationship. Ambassador Sheinwald argues that financially the US and EU need regulatory cooperation, using a scientific basis, to set global standards. He stresses as well that the EU is a major global power on its own. It is increasingly seen as an honest, multilateral broker and plays a crucial in global economic recovery. Moreover, it has strong interest in fighting world terrorism. In comparison to other partners, the US can find similar values, intelligence, and capacity in the EU. In addition, the US can see more stability in Europe’s own backyard than perhaps 20 years ago. Looking to the future, Ambassador Sheinwald hopes that the Lisbon Treaty would help the EU organize itself further. Further stressing the importance of the US-EU partnership, Ambassador Sheinwald explains “nothing is more likely to be as dependable a foundation.”

In taking the time to answer questions, Ambassador Sheinwald discusses a number of issues. One partiuclar area of focus much emphasized was Europe's role in the conflict in Afghanistan. In addition, he addresses the issue of Britain and the US's relationship with China. Moreover, he also explains that he hopes that as developed countries deal with increasing security threats, their resolve in keeping their borders open will remain strong. Finally, Ambassador Sheinwald stresses the need to employ methods of sustainable, intelligent, and low carbon growth.

About the Speaker

Nigel Sheinwald joined the British Diplomatic Service in 1976 and has served in Washington (twice), Brussels (twice) and Moscow and in a wide range of policy jobs in London. 

He took up his position as British Ambassador to the United States in October 2007.  In that role he leads the Embassy in Washington and nine Consulates-General around the United States.   He had an earlier posting to Washington in 1983-87 as First Secretary (Political) in the Embassy. 

Before becoming Ambassador in Washington, Sir Nigel served as Foreign Policy and Defence Adviser to the Prime Minister from 2003-2007.

Sir Nigel was the UK Ambassador and Permanent Representative to the European Union in Brussels from 2000-2003.  Before that he was Europe Director in the FCO (1998-2000).  He had an earlier posting in the UK Representation in 1993-95 as Head of its Political and Institutional Section.  He began his career in EU work as Deputy Head of the FCO's European Union Department in 1989-92. 

Sir Nigel's first foreign posting was in Moscow in 1978-79.  He was also Head of the Foreign Office's Anglo-Soviet Section in 1981-83.

Sir Nigel has had a wide variety of other appointments in the FCO in London.  From 1995-98, he was the FCO Press Secretary and Head of News Department.  He was Deputy Head of the Foreign Office's Policy Planning Staff in 1987-1989, responsible for transatlantic relations and other issues.  He also worked in London on the Japan Desk (1976-77) and on Zimbabwe (1979-81), including the Lancaster House Conference.

Sir Nigel was born in 1953 and educated at Harrow County Grammar School and Balliol College, Oxford.  He is married with three sons.

This event is jointly sponsored by the Office for International Visitors at the Bechtel International Center, the Forum on Contemporary Europe, and the British Consulate General in San Francisco.

CISAC Conference Room

Sir Nigel Sheinwald British Ambassador to the United States Speaker
Seminars
-

In this session of the Shorenstein APARC Corporate Affiliate Visiting Fellows Research Presentations, the following will be presented:

Hiroyuki Koyano, "The Strategy for Accerlation of Patent Examination - Focusing on Human Resource Management"

The number of patent application filings has increased across the world as a result of the globalization of the world economy. In addition, technology has become more complex and the demands for a quality patent has grown. Working against this trend, the period of patent examination has become longer, so patent offices have adopted plans to remedy the situation and accelerate patent examination. Hiroyuki Koyano attempts to compare the United States Patent and Trademark Office’s (USPTO) plans with those of JPO’s and analyze the problems focusing mainly on human resource management.

Mitsue Kurihara, "The Recent M&A Boom in Japan"

Mergers and Acquisitons in Japan have been booming since the late 1990s. What initially started as a method for industrial rehabilitation, today, M&A is put to use by many companies as part of their corporate strategy. Utilizing her experiences as an advisor for M&A, Kurihara researches the remarkable trend in the boom of Japanese M&A over the last ten years, as well as the future of Japanese M&A market in terms of where it should be headed.

Bhavna Sharma, “Polymorphisms in Breast Cancer Mutation Carriers: Comparative Studies in Caucasian and Hong Kong Population”

Breast cancer rates differ significantly in Asia compared to the United States and other western countries.  Lifestyle and genetic differences between these populations are probably causes of this variation.  Sharma presents findings from her study that hypothesized that the genetic breast cancer risk factors that differ between BRCA1/2 mutation carriers in Asia and the U.S. may result in a different magnitude of breast cancer risk among Asians versus Caucasians who carry BRCA1/2 mutations.

Philippines Conference Room

Hiroyuki Koyano Corporate Affiliate Visiting Fellow, Japan Patent Office Speaker
Mitsue Kurihara Corporate Affiliate Visiting Fellow, Development Bank of Japan Speaker
Bhavna Sharma Corporate Affiliate Visiting Fellow, Reliance Industries, India Speaker
Seminars
-

This presentation will discuss the current clinical diagnostic business scenario and the business opportunities available with a focus on the U.S. market.

 

About the speaker:

Sivaraman Vasudevan is a corporate affiliate visiting fellow at Shorenstein APARC for 2008-09.  Prior to joining Shorenstein APARC, he has been working for Reliance Life Sciences in Bangalore, India as Regional Head in charge of sales opoerations for Eastern and Southern parts of India.  His job responsibilities include developing business plans, implementing strategies and achieving sales targets.  Additionally, he is part of an elite corporate team in developing national and regional marketing strategies. 

Daniel and Nancy Okimoto Conference Room

Sivaraman Vasudevan Speaker
Seminars
Subscribe to India